Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs10190080 | chr2:24355569 | A/G | 0.00011 | 178 | 25.28 | 26.92 | 17.43 | KM Plot |
PCPG | rs10190141 | chr2:209965963 | G/C | 1.38E-9 | 177 | 19.87 | 24.1 | 26.57 | KM Plot |
PCPG | rs10194004 | chr2:24291080 | A/G | 0.000113 | 177 | 25.4 | 27.52 | 17.43 | KM Plot |
PCPG | rs10194297 | chr2:107257511 | G/A | 0.000336 | 172 | 26.57 | 21.95 | 25.87 | KM Plot |
PCPG | rs10195955 | chr2:24343474 | G/A | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs10195984 | chr2:24343556 | G/C | 0.00011 | 178 | 25.4 | 26.57 | 17.43 | KM Plot |
PCPG | rs10196728 | chr2:24327484 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs10196927 | chr2:24336467 | C/G | 0.000114 | 177 | 25.28 | 27.27 | 17.43 | KM Plot |
PCPG | rs10199711 | chr2:107227131 | A/C | 0.000239 | 176 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs10199985 | chr2:24337332 | C/A | 0.000114 | 177 | 25.28 | 27.27 | 17.43 | KM Plot |
PCPG | rs10200175 | chr2:24358787 | A/C | 0.000167 | 171 | 25.17 | 26.92 | 17.43 | KM Plot |
PCPG | rs10200481 | chr2:24337861 | C/A | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs10201331 | chr2:24323885 | A/T | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs10201535 | chr2:242517966 | G/A | 4.6E-5 | 177 | 25.87 | 29.57 | 19.75 | KM Plot |
PCPG | rs10202119 | chr2:118536277 | G/A | 1.73E-5 | 177 | 25.08 | 25.97 | 11.65 | KM Plot |